Compare GE HealthCare Technologies Inc. Common Stock (GEHC) vs Oracle Corporation (ORCL) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
GE HealthCare Technologies Inc. Common Stock vs Oracle Corporation — how do they compare? GE HealthCare Technologies Inc. Common Stock trades at $68.6 (market cap $30.93B), while Oracle Corporation trades at $128.22 (market cap $395.76B). The key difference: Oracle Corporation is far larger — about 12.8× GE HealthCare Technologies Inc. Common Stock's market cap, and Oracle Corporation pays the higher dividend (1.53%). Which is the better fit depends on your goals.
| GEHC | ORCL | |
|---|---|---|
Market Cap | $30.93B | $395.76B |
Volume | 5,033,451 | 45,051,114 |
Sector | Health | Technology |
52-Week High | $88.16 | $313.00 |
52-Week Low | $59.48 | $114.99 |
Enterprise Value | $39.39B | $519.57B |
Dividend Yield | 0.23% | 1.53% |
Typical Hold Time | — | 73 Days |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
GE HealthCare (GEHC) trades at $68.79, up 1.55% today, with a neutral technical signal. The company reported mixed quarterly earnings, beating in Q2 2026 but missing in Q1, and is set to announce Q3 results on October 28, 2026. Recent developments include a $945 million acquisition of SOFIE Biosciences to expand its PET radiopharmaceutical footprint, alongside ongoing securities fraud investigations noted in recent news.
The outlook is cautiously optimistic, supported by a strong analyst consensus with a $79.64 price target and no sell ratings. Key opportunities include growth from strategic acquisitions and AI innovations, while risks involve legal investigations, integration challenges from the SOFIE deal, and potential margin pressures from increased investing cash outflows in 2026.
Oracle (ORCL) trades at $143.22, up 4.24% today, but faces a bearish technical signal with the stock near support at $135. The company reported strong Q1 2026 earnings, beating EPS estimates with $2.11 versus $1.96 expected, and maintains robust profitability with a 26.36% net income margin. Revenue growth accelerated to $57.4 billion in 2025, up from $53.0 billion in 2024, driven by AI cloud demand.
Outlook remains positive given analyst consensus price target of $236.52, implying significant upside, but risks include high debt levels and sensitivity to Fed policy. The stock's current valuation at a P/E of 22.45 appears reasonable relative to earnings growth, though investor sentiment is cautious amid recent layoffs and market volatility.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About GE HealthCare Technologies Inc. Common Stock
GE HealthCare Technologies Inc. is a medical technology company, spun off from General Electric in 2023, that develops imaging systems, ultrasound devices, patient monitoring equipment, and diagnostic imaging agents. Its product lines include CT, MRI, and mammography systems alongside anesthesia delivery and maternal-infant care solutions.
Read more on GEHC →About Oracle Corporation
Oracle provides database technology and enterprise resource planning, or ERP, software to enterprises around the world. Founded in 1977, Oracle pioneered the first commercial SQL-based relational database management system. Today, Oracle has 430,000 customers in 175 countries, supported by its base of 136,000 employees.
Read more on ORCL →
